Literature DB >> 16508439

Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection.

Frederick H Davidorf1, J Garret Mouser, Robert J Derick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16508439     DOI： 10.1097/00006982-200603000-00017

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  48 in total

Review 1.  Medical and surgical treatment of neovascular glaucoma.

Authors:  Lisa C Olmos; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2011

2.  Intracamaral bevacizumab in neovascular glaucoma with scleromalasia and retinal detachment.

Authors:  Suleyman Ciftci
Journal:  BMJ Case Rep       Date:  2009-11-18

3.  Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.

Authors:  L C Olmos; M S Sayed; A L Moraczewski; S J Gedde; P J Rosenfeld; W Shi; W J Feuer; R K Lee
Journal:  Eye (Lond)       Date:  2015-12-18       Impact factor: 3.775

4.  Combined pars plana vitrectomy and Baerveldt glaucoma implant placement for refractory glaucoma.

Authors:  Thalmon R Campagnoli; Sung Soo Kim; William E Smiddy; Steve J Gedde; Donald L Budenz; Richard K Parrish; Paul F Palmberg; William Feuer; Wei Shi
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

5.  Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.

Authors:  P J Rosenfeld
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

6.  Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.

Authors:  M S Spitzer; B Wallenfels-Thilo; A Sierra; E Yoeruek; S Peters; S Henke-Fahle; K U Bartz-Schmidt; P Szurman
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

Review 7.  Neovascular glaucoma.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2007-08-08       Impact factor: 21.198

8.  Intravitreal injection of bevacizumab to treat neovascular glaucoma.

Authors:  Toshiaki Kubota; Rumi Aoki; Yukinori Harada; Norihiko Tou; Akihiko Tawara
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

9.  Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy.

Authors:  Ashraf M El-Batarny
Journal:  Clin Ophthalmol       Date:  2008-12

10.  Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye.

Authors:  A Raghuram; V R Saravanan; V Narendran
Journal:  Indian J Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 1.848
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.